Schedule 13G ownership disclosure
Celsus Therapeutics
Security class unavailable · CUSIP: 15119A202
Event date: 2014-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 12.6000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000038777-15-000166
- Form type
- SC 13G
- Filer
- Akari Therapeutics Plc
- CIK
- CIK 1541157
- Filed
- Feb 17, 2015
- Reporting period
- Dec 31, 2014
- Description
- Schedule 13G beneficial ownership